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There have been several reports of non-ethical 
conduct of health research in developing countries. In 
some cases research does not conform to international 
standards, and researchers do not always respond to 
the health needs and priorities identified. Most of these 
cases have been in sub-Saharan Africa.[1,2] The more vulnerable groups 
in such populations have been most exploited. Poor sanitation, lack 
of adequate healthcare services and illiteracy, among other factors, 
mean that citizens of developing countries are often plagued with 
a range of diseases. These countries have therefore become a fertile 
ground for medical research, especially by pharmaceutical companies.
In Nigeria it is easy to find volunteers for trials because of 
widespread disease, poverty, and the large population. There was no 
means of enforcing ethical practices in health research in Nigeria until 
recent developments following the negative publicity that resulted 
from testing of the drug trovafloxacin (Trovan) by the drug company 
Pfizer during a bacterial (meningococcal) meningitis epidemic in 
Tudun Wada, Kano, Northern Nigeria, in 1996.[3] At least 11 children 
died during the course of the trial, and several others suffered brain 
damage and paralysis.
Subsequent to this incident, the National Health Research Ethics 
Committee (NHREC) was established in October 2005. The National 
Code of Health Research Ethics of August 2007,[4] produced by 
the NHREC, regulates all processes concerning research in Nigeria. 
The code also contains criteria for the registration and functioning of 
institutional or regional health research ethics committees (HRECs).
Objective
To document the current role of HRECs in ensuring ethical practices 
in health research in Nigeria, and to identify the strengths and 
weaknesses of their process of ethical review.
Methods 
Nigeria has six geopolitical zones. The country was divided into 
northern and southern regions along tribal, cultural and religious 
lines, and further subdivision into six zones ensured that all 
minority and majority tribes are represented. Three HRECs from 
three geopolitical zones (North-Eastern (Maiduguri), South-Western 
(Ibadan) and South-South (Calabar)) were selected, and 14 members 
in total were recruited after a process of simple random sampling. Two 
of the HRECs were institutional and based in universities, while the 
third was a regional state government HREC. The study was carried 
out between June and August 2011.
The invitation to be interviewed was made via telephone or email. 
The date, time and place chosen for the interview were designed to 
be convenient to the participant. After written and signed consent 
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Background. Ethics are rules or standards governing the conduct of a person or members of a profession. Medical research must be 
regulated to ensure that fundamental human rights are not breached in the quest for knowledge. Nigeria had no laws or specific guidelines 
to regulate health research until 2007, when a national regulatory body, the National Health Research Ethics Committee (NHREC), was 
established. Its function is to ensure ethical conduct in research and to accredit institutional and state health research ethics committees 
(HRECs).
Objective. To document the current role of HRECs in the ethical practice of health research in Nigeria, 4 years after the establishment of 
the NHREC.
Methods. Functioning of the HRECs was evaluated via interviews of 14 members of state and institutional HRECs chosen from selected 
geopolitical zones of the country.
Results. The HRECs surveyed had between nine and 15 members, with more males than females. Review meetings were held only occasionally 
owing to the competing interests of members, who receive no incentives for participation, and poor funding. Scientific and ethical reviews 
are conducted together by the same committee, but few members of the HRECs are trained in research ethics. Monitoring of research after 
approval is poor.
Conclusion. Nigeria now has about 30 institutional HRECs, but their functioning is hampered by a shortage of both money and qualified 
individuals to serve on them. 
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had been obtained, semi-structured interviews (Appendix 1) were 
conducted with individual participants using an interview schedule 
that had been validated using pre-tests. All interviews were audiotaped 
and then transcribed to respect the participants’ speaking style, and 
each lasted 30 - 60 minutes. Consent was obtained before the use of 
the audio tape recording, and if consent to tape the interview was not 
given, secretarial staff recorded the response in written form.
Ethical approval was obtained from the National Health Research 
Ethics Committee of Nigeria (NHREC) (ref. no. NHREC/01/01/2007-
04/05/2011).
Data were analysed using N6 qualitative software (QSR Inter-
national). Analysis aimed to describe the functioning of the 
HREC, focusing on the membership of the committees, their 
representativeness, their independence from research sponsors, and 
the institutions in which they were based.
Results
A total of 14 HREC members were interviewed, only two of whom 
were females, giving a male:female ratio of 7:1.
The membership of the HRECs studied ranged from nine to 15. 
People often became members because of positions they held in 
the government or an institution, and membership was sometimes 
based on experience in ethics as a subject. Tenure of membership was 
therefore frequently related to tenure of the position held. However, 
only a few (<30%) of the HREC members had formal training in 
research ethics. All the HRECs had legal advisers.
All researchers who submitted proposals for ethical review paid 
a fee of between 2 000 and 20 000 Nigerian naira (US$1 = ~N150), 
the fee being higher for sponsored projects. It was the applicants’ 
responsibility to submit enough hard copies of their proposals for all 
members of the HREC.
The frequency of HREC meetings to review submitted proposals 
ranged from fortnightly to quarterly. Scientific and ethical reviews 
were conducted together by the same committee. All the HRECs 
followed the guidelines of the NHREC, which is the national and 
supervising body. After approval, two of the HRECs did not monitor 
approved projects and the only HREC that monitored approved 
proposals relied solely on funding by the researcher to do so.
Two of the three HRECs relied solely on the processing fees paid by 
the researchers to fund the committees, while committee functioning 
in the third was funded by the institution in which it was based.
The HRECs ensured that participants with an excessive risk 
of harm were excluded from studies if possible. These included 
children, pregnant women, and members of socially, culturally, 
economically, politically, educationally, physically and psychologically 
disadvantaged groups. Specific safeguards were used to protect 
vulnerable subjects involved, appropriate to the degree of risk.
Social and cultural factors that sometimes limited application 
of international ethical norms to research proposals during ethical 
reviews in Nigeria included the low level of education of much of the 
population, religious beliefs, lack of understanding of the concept of 
research on the part of most Nigerians, and unco-operative attitudes 
among some research participants, who viewed the researchers as 
strangers in their community.
Most HREC members understood the concepts of autonomy and 
consent in research. With regard to issues relating to beneficence 
and non-harm to participants in the review of research protocols, 
most committees were multidisciplinary in composition, and experts 
in relevant fields were frequently asked to evaluate the risks and 
benefits to research participants. Financial compensation to research 
participants was usually not made compulsory for researchers, 
but incentives such as transport and refreshment allowances were 
advised when there was no direct benefit to the research participant.
Challenges faced by the HRECs included irregular meetings due 
to committee members’ busy schedules, haphazard selection of 
members, and lack of remuneration or incentives for members.
Discussion
Ethics are the rules or standards governing the conduct of a person or 
the members of a profession. The medical profession deals with human 
life, and research is an integral part of medicine. However, medical 
research must be regulated in order to ensure that fundamental 
human rights are not breached in the quest for knowledge. Before 
the 1960s, researchers were thought to be responsible and they were 
quite free to conduct ‘good research’. However, from the 1960s, ethics 
became a concern in the world of health and biomedical research.
Researchers in developed countries have realised that using 
developing countries for their trials incurs lower costs compared 
with traditional research areas. Furthermore, less strict (or lack of ) 
legislation means that research protocols are accepted more easily 
and sooner than in developed countries. If preparatory procedures 
are done quickly, the company will have more time to optimise 
profits within the patent period. Also, volunteers for trials are easy 
to find in developing countries because of widespread disease and 
abject poverty. Although various organisations have been promoting 
ethical health research in Africa in conformity with international 
ethical guidelines,[5] Nigeria, as a developing country with a large 
population, is prone to exploitation by researchers, a classic example 
of which is the Pfizer testing of trovafloxacin on children with 
meningitis in 1996.[3] Before 2005, only the National Agency for Food 
and Drug Administration and Control (NAFDAC) had jurisdiction over 
medical research in the country, especially research involving drug 
trials. However, the NAFDAC focused largely on food safety and drug 
control and paid little attention to ethics in medical research.
Nigeria had no laws or specific guidelines to regulate health research 
until the NHREC was established in 2005 by the Minister of Health as 
the body responsible for ensuring the protection of human research 
participants. The National Code of Health Research Ethics was produced 
by the NHREC in August 2007 and regulates all processes concerning 
research in Nigeria, such as granting approval for research, research 
supervision, and processes for suspension, revision or termination of 
research. International codes served as guidelines for the production of 
this code, with adjustments to cater for Nigeria’s specific sociocultural 
environment. Kirigia et al.[6] recommended that African countries 
should adopt international guidelines on biomedical research, pass 
laws on standards and regulations to strengthen the ethical review 
framework, and develop governance mechanisms to make sure that 
their HRECs approve projects in accordance with the Council for the 
International Organizations of Medical Sciences (CIOMS) guidelines 
of 2002.[7] The national code is easily accessible by researchers, as it is 
available online (www.nhrec.net).
The NHREC has published a list of accredited HRECs, also known as 
ethics review committees or institutional review boards or committees, 
in various parts of Nigeria. Although the country now has about 
May 2014, Vol. 7, No. 1    SAJBL     21
ARTICLE
30 institutional HRECs, our study and previous work show that their 
functioning is hampered by a shortage of qualified individuals to serve 
on them, together with an imprecise definition of mandates and a highly 
scientific membership.[8,9] Evaluation work done by committee members 
is voluntary, and ethical review is very limited. Under such circumstances, 
even if laws are in place it may be difficult to enforce and apply them.
We found that financial shortages faced by the HRECs mean that 
there is also inadequate monitoring of approved research protocols 
to ensure strict compliance by researchers. A study published by 
Kass et al.[10] on the organisation and functioning of 12 ethical review 
committees in nine African countries identified two similar main 
issues: lack of training of ethical review committee members, and lack 
of funding. These same issues were discussed by African participants, 
and participants from other regions of the world, during the Third 
International Bioethics Meeting of French-speaking Countries held 
in Quebec in October 2008 on the topic ‘A new governance, diversity, 
and sharing space of Francophone countries’.
Conclusions and recommendations
In view of the scale of previous ethical breaches in some research 
projects in Africa, and in Nigeria specifically, compliance with 
national and international ethical standards is vital. Ethical issues in 
the Pfizer testing of trovafloxacin in 1996[3] provided the impetus for 
change in the conduct of health research in Nigeria. However, our 
study shows that the HRECs still face many challenges. Suggested 
recommendations for improvement are:
• Allocation of more funding to the NHREC and HRECs for better 
functioning.
• Provision of financial incentives to HREC members to motivate 
them and improve their commitment.
• Proper monitoring and supervision of projects by the HRECs to 
ensure that researchers comply with approved project formats.
• Training and re-training of HREC members to update them on 
ethical principles.
• Training of researchers and undergraduate students in the health 
professions on research ethics.
• An increase in research funding and promotion of autonomy of 
researchers from funders.
• Establishment of a forum for all HRECs in the country to meet and 
share knowledge and exchange ideas. This may be co-ordinated 
by the NHREC.
• To ensure relevance of research to the population, research findings 
should be submitted to the approving HREC. An agency may be set 
up by the government to collate all such research findings in the 
state or country to influence government policies.
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Appendix 1. Interview guide for Health Research Ethics Committee members 
a) Functioning of the HREC
When was the committee formally established?
What are the functioning modalities and the committee membership? 
What are the criteria for selecting members of the committee?
How many members of the committee have been trained in research ethics? 
How frequently does the committee meet?
What are the procedures of protocol or proposal approval?
What are the normative regulations used? 
What are the specific regulations used? 
What are the special arrangements made for vulnerable populations such as women, elderly people, children, migrants?
Are the ethical review and the scientific review conducted together or separately? 
Does the same committee conduct both the ethical and scientific review of the proposals?
How is the committee funded? 
Do you have dedicated staff and office space for the committee?
What are the relationships between the various committees in the country?
What are the main challenges confronting the smooth operation of the committee?
What suggestions would you make to address these challenges?
 
b) Ethical principles and rules
International regulations (Council for the International Organizations of Medical Sciences, Good Clinical Practice, Declaration of Helsinki, etc.) 
state that research ethical principles include respect for research subjects, beneficence (and non-harming), and justice. How do you think these 
principles could be applied, taking into account the situation of individuals in Nigeria? 
What sociocultural factors in Nigeria complicate the application of international ethics rules?
How do you understand the concept of autonomy of research participants in the Nigerian context?
How do you understand the concept of consent of research participants in the Nigerian context? What difficulties have researchers been 
confronted with in getting consent from research participants? How can illiterate participants be helped to truly understand the research 
objectives and the scientific terms? 
How do you understand the concept of beneficence in the review of research projects in the Nigerian context? 
How do you understand the concept of justice in the review of research projects in the Nigerian context? 
How do you assess the fairness of the financial compensation proposed by researchers to research participants? 
 
c) Ethical monitoring of the protocol
Is there any ethical monitoring of the protocol after approval by your ethical review committee? 
If yes, who is in charge of the monitoring? How is the monitoring funded? 
Has ethical monitoring of the protocol taken into account vulnerable populations (children, adults with disabilities, dependent populations/care) 
and/or the level of risks?
Does the researcher draft an annual monitoring report? Does the report include the number of subjects recruited, and the number who have 
withdrawn from the research? 
Is there any ethical monitoring of the protocol with regard to:
• observation of the consent process?
• control of how research documents and duly signed consent forms are kept?
• notification of modifications to the protocol, the administrative modifications?
• re-submission of application to the ethical committee in case of modifications to the protocol?
 
d) Comments
What do you see as the key challenges confronting researchers with regard to conforming to the standards of ethics?
Do you have suggestions to improve the framework of ethical research?
